Does Immune Signaling Contribute to PARP inhibitor induced Synthetic Lethality?

Authors

Mona Shirvani, The University of Texas MD Anderson Cancer CenterFollow
Eszter Dombi, The University of Texas MD Anderson Cancer Center
Katharina Schlacher, The University of Texas MD Anderson Cancer Center

Files

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston

Keywords

BRCA2, synthetic lethality, PARP inhibitor, immune signaling, TNFαi

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Program Affiliation

CPRIT-CURE Summer Undergraduate Program

Recommended Citation

Shirvani, Mona; Dombi, Eszter; and Schlacher, Katharina, "Does Immune Signaling Contribute to PARP inhibitor induced Synthetic Lethality?" (2021). Summer Experience 2021. 159.
https://openworks.mdanderson.org/sumexp21/159